New

ETF model portfolios designed for real investor needs. Discover →

Advertisement
Advertisement

Topic

Health

Utilities consumer staples and healthcare
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities

Here's what you need to know about the three defensive sectors in the S&P 500

Latest news about Health

Obesity and Weight-Loss Drugs: A New Thematic ETF Segment?

The ongoing Ozempic and weight-loss drug obsession has investors and ETF issuers turning to new ways of gaining healthcare sector exposure.

Weight-loss-drugs

Healthcare Stocks Drop on Medicare Payment Rate Surprise

Shares of major U.S. health insurers have taken a significant hit as the final 2025 Medicare Advantage plan payment rates fall short of industry expectations, raising concerns about margins.

Healthcare ETFs drop
Rony Abboud
By Rony Abboud · April 8, 2024

Notable ETF Filings Recap: March 2024

Here's a look at some of the most interesting prospective ETFs awaiting regulatory review and approval as of March.

Files and documents piles

Healthcare Funds on the Rise

Health Care sector sees a modest 2023 finish after a decline in 2022, sparking renewed interest with substantial inflows this week.

refill of liquid on tubes
ETF Central
By ETF Central Team · January 9, 2024

Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze

Ozempic, Wegovy, and Mounjaro – here's how the latest weight-loss drugs could affect some pharmaceutical and food ETFs.

Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze

Upside & Impact Ep. 4 - What Happened to the Beyond Meat and Oatly stocks?

Dr. Sasha Goodman, Chief Investment Officer of VegTech Invest, joins Elysabeth Alfano, CEO of VegTech Invest to discuss what has happened to the Beyond Meat and Oatly stocks and, conversely, the large landscape of Plant-based Innovation companies in the public markets that are thriving.

Upside & Impact Ep. 4 - What Happened to the Beyond Meat and Oatly stocks?
Elysabeth Alfano headshot
By Elysabeth Alfano · November 16, 2023

Two biotech ETFs to watch for the rest of 2022 and beyond

Investors with a high tolerance for risk may seek to gain exposure to the growth potential of the biotech industry. We take a look at two ETFs that have rallied over the last month.

Two biotech ETFs to watch for the rest of 2022 and beyond
Alan Joseph
By Alan Joseph · September 13, 2022
Advertisement
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides

Recent educational content

Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 8, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 9, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 31, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 1, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 24, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · August 24, 2026
What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

What’sTheFund

What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

James St Aubin, Chief Investment Officer at Ocean Park Asset Management, discuss the DUKZ ETF, exposing investors to the whole spectrum of asset classes in the fixed income markets, through their rules-based process.

NYSE logo
By NYSE · August 18, 2026

Browse all educational columns

ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder